Skip to main content

Quantinuum

Quantinuum Inc. is a Delaware-incorporated advanced technology enterprise headquartered in Broomfield, Colorado, explicitly established to operate as the publicly traded holding entity for its Cayman Islands-based quantum computing business. Originally formed in 2021 through the strategic combination of Honeywell Quantum Solutions and Cambridge Quantum, the company maintains a vertically integrated computing platform that actively develops both sophisticated quantum hardware systems and corresponding application software. Its commercial product offerings encompass cloud-based and on-premises quantum hardware access, customized developer middleware, specialized application libraries, and outcome-oriented intellectual property licensing. The firm directly collaborates with major corporate partners—including JPMorgan Chase in financial services and Amgen in pharmaceuticals—to extensively research, build, and validate high-value quantum applications targeting complex computational problems. Utilizing a hybrid architectural approach, the company directly integrates its quantum processing capabilities with classical and accelerated computing frameworks to reliably deploy advanced solutions in real-world environments. Following its initial public offering, the industrial conglomerate Honeywell remains the company's largest principal stockholder, holding a significant portion of the combined voting power while continuing to act as a crucial strategic customer.

3 of the funds FundTelligence covers report a position in Quantinuum.

Legal name
Quantinuum Inc
Sector
Information Technology
Country
United States
Funds holding it
3
Exposure themes
Frontier Technologies, Quantum Computing, Technology Themes

Funds holding Quantinuum

Loading...